Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of health-care revenue management expert Accretive Health
So what: The third-quarter report missed Street targets by slim margins on both the top and bottom lines, and management also slashed the fourth-quarter outlook.
Now what: Accretive is a tremendously volatile stock that has gained 161% in fits and starts over the last 52 weeks -- yes, even after today's terrible drop. Rivals athenahealth
Interested in more info about Accretive Health? Click here to add it to My Watchlist.
Fool contributor Anders Bylund holds no position in any of the companies mentioned. We Fools may not all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Check out Anders' holdings and bio, or follow him on Twitter and Google+. We have a disclosure policy.